The FemX Wv aminoacyl transferase of Weissella viridescens initiates the synthesis of the side chain of peptidoglycan precursors by transferring L-Ala
INTRODUCTION
Bacterial resistance to antibiotics will lead to therapeutic deadlocks unless new drugs are discovered. Only two families of antibiotics act on peptidoglycan polymerization, the b-lactams and the glycopeptides. Development of new generations of molecules derived from these antibiotics is not sufficient to defeat the sophisticated resistance mechanisms responsible for the gradual loss of activity against main human pathogens, such as the pneumococci and the staphylococci, responsible for lifethreatening pneumonia, meningitis and sepsis. Blocking synthesis of the substrate of peptidoglycan polymerases is an attractive strategy to develop new antibiotics but this approach requires a better understanding of the substrate specificity and catalytic mechanism of the essential enzymes since screening of natural substances has led to very limited success in the discovery of novel molecules. Here, we report characterization of FemX Wv , the model enzyme of a unique family of tRNA-dependent aminoacyl transferases that have not been previously explored as drug targets because of the complexity of their nucleotide substrate. Key features in the recognition of Ala-tRNA Ala by FemX Wv validate these enzymes as potential drug targets.
The peptidoglycan is an essential component of the bacterial cell envelope, since it provides a mechanical barrier to the internal osmotic pressure of the cytoplasm (1) . The peptidoglycan subunit is assembled by a series of cytoplasmic and membrane steps ( Figure 1 ) that lead to formation of nucleotide (UDP-linked) and lipid intermediates. The complete subunit is translocated to the cell surface by an unknown mechanism and polymerized by the glycosyltransferases, that form the b-1-4 bonds linking the repeating GlcNAc-MurNAc units (2) , and by the D,D-transpeptidases, that form peptide bonds between stem peptides in order to cross-link adjacent glycan strands (3) . The latter activity is the target of b-lactam antibiotics that mimic the D-Ala 4 -D-Ala 5 extremity of peptidoglycan precursors (4) and act as 'suicide' substrates in an essentially irreversible acylation reaction (5) . In Gram-positive bacteria, b-lactam resistance is often due to so-called low-affinity penicillin-binding proteins (PBPs) that interact poorly with b-lactams and catalyze peptidoglycan cross-linking in the presence of the drug (3) .
A wide variety of modifications of the disaccharidepeptide subunit has been detected in mature peptidoglycan from Gram-positive bacteria, including the addition of a side chain comprising one to seven amino acids to the e amino group of L-Lys 3 (6) . These modifications are introduced in the subunit at different steps of peptidoglycan synthesis and can therefore involve the nucleotide precursor as well as both lipid intermediates (7) . The dicarboxylic amino acid D-Asp is incorporated into the side chain by aspartate ligases that belong to the ATPGrasp superfamily and activate their substrate by ATP-dependent formation of a b-aspartyl-phosphate intermediary (8) . In contrast, L-amino acids and glycine are activated as aminoacyl-tRNAs (9) and incorporated into the side chain by Fem transferases (10) that belong to the GCN5-related N-acetyltransferase (GNAT) protein superfamily (11, 12) . Characterized members of this family include FemX Wv from Weissella viridescens that transfers L-Ala from L-Ala-tRNA Ala to UDP-MurNAcpentapeptide (13, 14) (Figure 1 ) and FemABX from Staphylococcus aureus that sequentially add one (FemX) or two (FemA and FemB) glycines to lipid II (15) . FemX Wv catalysis proceeds by an ordered bi-bi mechanism with sequential fixation of the UDP-MurNAcpentapeptide and Ala-tRNA Ala substrates and sequential release of the tRNA Ala and UDP-MurNAc-hexapeptide products (14) . Binding of the first substrate to FemX Wv involves a complex network of hydrogen bonds and stacking interactions that constraint UDP-MurNAcpentapeptide in a bent conformation essential for transferase activity (13) . The mode of interaction of FemX Wv with the second substrate, Ala-tRNA Ala , as well as the catalytic mechanism of the enzyme remains speculative (14) .
The side chain of peptidoglycan precursors assembled by Fem transferases carries the amine used for peptide bond formation by the transpeptidases in the last crosslinking step of peptidoglycan polymerization ( Figure 1 ) (13, 16) . The specificity of Fem transferases is essential for the bacterium since incorporation of erroneous amino acids would produce precursors acting as chain terminators, thereby preventing formation of the stress-bearing peptidoglycan network. In spite of its critical role for the integrity of peptidoglycan, little is known about the amino acid specificity of Fem transferases. Surprisingly, FemX Wv was reported to poorly discriminate between Ala-tRNA Ala and Ser-tRNA Ser in vitro (14) . The specificity constant k cat /K m for the two aminoacyl-tRNAs differed only 11-fold implying a likely incorporation of both amino acids into the peptidoglycan precursors (14) . In this report, we have evaluated the in vivo specificity of FemX Wv by mass spectrometry analyses of peptidoglycan and its precursors. The in vitro specificity of the enzyme was also evaluated by comparing the catalytic efficiency of the enzyme with natural tRNAs extracted from different bacterial species or obtained by in vitro transcription. The modes of recognition of the acceptor stem of the tRNA by FemX Wv and alanyl-tRNA synthetase were compared based on saturation mutagenesis and semi-synthesis of Ala-tRNA Ala analogues.
MATERIALS AND METHODS

Preparation and analysis of cytoplasmic peptidoglycan precursors
Bacteria were grown at 308C to an optical density at 650 nm of 0.75 in Man, Rogosa and Sharpe (MRS) broth (Biorad). Bacitracin (250 mg/ml) was added to inhibit dephosphorylation of undecaprenyl diphosphate and incubation was continued for 30 min to accumulate cytoplasmic peptidoglycan precursors. Extraction of the precursors with formic acid and separation by rp-HPLC in a C18 column with a methanol gradient (0-20%) in 50 mM ammonium formiate (pH 4.0) was performed as previously described (17) . The precursors were analyzed by mass spectrometry using an electrospray time-of-flight mass spectrometer operating in positive mode (Qstar Pulsar I, Applied Biosystem, Courtaboeuf, France) (18) . The sequence of the precursors was determined by tandem mass spectrometry with nitrogen as the collision gas (18) .
Peptidoglycan structure analysis
Bacteria were grown at 308C to an optical density of 0.75 at 650 nm in MRS broth. Peptidoglycan was extracted with boiling SDS, treated with proteases and digested with mutanolysin and lysozyme, as previously described (16) . The resulting muropeptides were treated with ammonium hydroxide to cleave the ether link in MurNAc, separated by rp-HPLC and analyzed by mass spectrometry and tandem mass spectrometry (16) .
Enzyme production and purification
The same procedures were used for production and purification of the proteins unless specified otherwise. Genes were amplified by PCR and cloned into the vector pTrc-His60 (19) in order to introduce a C-terminal 6XHis tag in the recombinant proteins. Derivatives of Escherichia coli TOP10 harboring recombinant plasmids were grown to an optical density at 600 nm of 0.7 in brain heart infusion broth (Difco) containing 100 mg ml À1 of ampicillin, isopropyl-b-D-thiogalactopyranoside was added to a final concentration of 0.5 mM, and incubation was continued overnight at 168C. Bacteria were harvested by centrifugation (4200Âg for 30 min at 48C), resuspended in 50 mM Tris-HCl (pH 7.5) containing 300 mM NaCl (buffer A), and disrupted by sonication with a Branson Sonifier 450 for 2 min with cooling. The extract was centrifuged at 13 800 Â g for 30 min at 48C and the supernatant was mixed with a HIS-Select TM nickel affinity gel (SIGMA, Saint Louis, Missouri, USA) for affinity purification. Proteins eluted with imidazole were dialyzed against buffer A containing 100 instead of 300 mM NaCl prior to anion exchange chromatography on a Mono Q 5/50 GL column (Amersham Biosciences, Piscataway, USA) with an NaCl gradient in Tris-HCl (pH 7.5). Size exclusion chromatography was performed on a Superdex 75 HR 10/30 Õ column (Amersham Biosciences) equilibrated in buffer A. Protein concentration was determined by using the Bradford reagent (Bio-Rad, Munich, Germany) with bovine serum albumin as a standard. Proteins were stored at À208C in buffer A supplemented with 50% glycerol.
The recombinant plasmid encoding the FemX Wv transferase of W. viridescens has been previously described (13) . The protein was purified by affinity, anion exchange and size exclusion chromatographies.
The aminoacyl-tRNA synthetases were purified in two steps by affinity and anion-exchange chromatographies. Construction of the recombinant plasmid encoding the alanyl-tRNA synthetase of Enterococcus faecalis JH2-2 (AlaRS) has been previously described (20) . The same cloning approach was used to construct recombinant plasmids encoding the glycyl-tRNA synthetase of S. aureus Mu50 (GlyRS) and one (EF3292) of the two seryl-tRNA synthetases of E. faecalis JH2-2 (SerRS).
The gene encoding the T4 RNA ligase was cloned into pTrc-His60 and the enzyme was purified by affinity, anion exchange and size exclusion chromatographies. For production of the T7 RNA polymerase, we used a pQE30 derivative in E. coli M15 (a kind gift of K. Tomita). The protein was purified in a single step by nickel affinity chromatography followed by dialysis against Tris-HCl 50 mM (pH 7.5), MgCl 2 10 mM, KCl 200 mM and dithiothreitol 2 mM. The protein was stored in the same buffer supplemented with 50% glycerol.
DNA templates for preparation of tRNAs by in vitro transcription
The sequence of the tRNA Ala used in this study (5 0 -GGGGCCUUAGCUCAGCUGGGAGAGCGCCU GCUUUGCACGCAGGAGGUCAGCGGUUCGAUC CCGCUAGGCUCCACCA-3 0 ) corresponds to the three identical sequences annotated as tRNA Ala in the genome sequence of E. faecalis strain V583 (http://www.tigr.org/) (13 Ala sequence could not occur in the following step since the pUC derivative used for PCR amplification did not carry the T7 promoter and the first five bases of the tRNA.
In vitro transcription
The assay was performed at 378C for 4 h in a total volume of 1 ml containing NTPs (4 mM each, Amersham), GMP (20 mM), a DNA template (ca. 100 pmol), T7 RNA polymerase (100 mg), Triton Â100 (0.05% V/V), MgCl 2 (15 mM), spermidine (2 mM), dithiothreitol (10 mM) and Tris-HCl (40 mM, pH 7.5). The reaction mixture was incubated 20 min at 658C, DNAse was added (30 U; RQ1 RNase-Free DNAse, Promega) and incubation was continued for 1 h at 378C. RNA was extracted with one volume of phenol (pH 4.5), followed by one volume of phenol/chloroform (1/1 V/V), and precipitated with 2 volumes of ethanol at À208C overnight. RNA was centrifuged at 48C, the pellet was washed three times with 70% ethanol, dried under vacuum and dissolved in 100 ml of water. The RNA was incubated for 1 min at 858C and slowly (ca. 45 min) cooled to room temperature by switching off the heating of the water bath. The RNA was purified by size exclusion chromatography (Superdex Õ 75 HR 10/30, Pharmacia) in Tris-HCl (25 mM, pH 7.5) containing 100 mM NaCl and 5 mM MgCl 2 . The concentration of tRNA was determined by aminoacylation as described subsequently. A simplified procedure was used for the analysis of RNA molecules obtained by sitedirected mutagenesis of tRNA Ala . Briefly, size exclusion chromatography was omitted and the concentration of tRNA was estimated following ethidium bromide staining of denaturing polyacrylamide gels containing appropriate dilution of purified tRNA Ala used as a standard.
Purification of natural tRNAs
The method of Meinnel and Blanquet (22) was used to extract tRNA from four bacterial species representative of the polymorphism at the third position of peptidoglycan precursors including W. viridescens CIP 102810 T (formerly Lactobacillus viridescens ATCC 12706), E. faecalis JH2-2 (23), Enterococcus faecium D344S (17) and S. aureus COL. Briefly, bacteria were grown at 378C to mid log phase (optical density of 0.7 at 600 nm) in MRS broth for W. viridescens or in brain heart infusion broth (Difco) for the other strains. Bacteria were concentrated 100-fold by centrifugation, resuspended in Tris-HCl 10 mM (pH 7.5) containing magnesium acetate 10 mM, and the tRNAs were extracted from bacterial suspensions with one volume of phenol (pH 4.5). NaCl was added to obtain a concentration of 0.5 M and the tRNAs were precipitated with 0.7 volume of isopropanol at À808C for 30 min. Deacylation was performed in Tris-HCl (pH 8.0) for 2 h at 378C. The tRNAs were dialysed against water, lyophilized and dissolved in water. The concentration of the tRNAs was determined by the absorbance at 260 nm.
Acylation of tRNAs
The concentration of tRNA was determined based on full aminoacylation with a high concentration of aminoacyltRNA synthetases (800 nM) that was shown to be sufficient for full acylation in less than 1 min. ; Perkin Elmer). The reaction was incubated 8 min at 378C and aminoacyl-tRNAs were precipitated with 5% TCA and 0.5% casamino acids, filtered on glass-fiber filters and determined by liquid scintillation counting.
FemX Wv coupled assay
The transferase activity of FemX Wv was determined in a coupled assay containing an auxiliary system to generate aminoacyl-tRNAs as described by Maillard et al. (13) with minor modifications. The assay contained 50 mM Tris-HCl (pH 7.5), 12.5 mM MgCl 2 , 2 mM b-mercaptoethanol, 7.5 mM ATP, 800 nM aminoacyl-tRNA synthetase, 50 mM UDP-MurNAc-pentapeptide, 50 mM of [
14 C] amino acids and tRNAs at the concentrations specified in the text. The reaction was performed at 308C with a preincubation of 10 min prior to the addition of FemX Wv for synthesis of the aminoacyl-tRNAs by the auxiliary system. The concentration of FemX Wv (0.5-500 nM) was adjusted to obtain initial velocities in conditions where transferase activity was rate-limiting. Under such conditions, the tRNAs were completely acylated at the onset of the FemX Wv reaction and remained fully acylated during the entire reaction, as judged by direct determination of aminoacyl-tRNAs. The reaction was stopped at 958C for 10 min and analysed by descending paper chromatography (Whatman 4MM, Elancourt, France) with isobutyric acid : ammonia 1 M (5 : 3 per vol). Radioactive spots were identified by autoradiography, cut-out and counted by liquid scintillation.
Synthesis of N-(4-pentenoyl)-L-alanine cyanomethyl ester
To a solution of pentenoic acid (500 ml, 4.9 mmol) in DME (18 ml) cooled down to À108C were added successively N-methylmorpholine (539 ml, 4.9 mmol) and isobutyl chloroformate (640 ml, 4.9 mmol). In another flask, a mixture of alanine methyl ester hydrochloride (684 mg, 4.9 mmol) and N-methylmorpholine (539 ml, 4.9 mmol) in DME (2 ml) was stirred for 10 min at room temperature before being added dropwise to the first solution. The reaction was stirred overnight at room temperature, quenched with H 2 O and DME was evaporated under reduced pressure. The aqueous layer was extracted twice with DCM and organic layers were gathered and washed successively with saturated aqueous NaHCO 3 solution, HCl (0.5 M) and brine. After drying over MgSO 4 and concentrated under reduced pressure, the N-(4-pentenoyl)-L-alanine methyl ester was obtained as a yellowish oil (92% yield) which was used without any further purification. To a solution of this compound (834 mg, 4.5 mmol) in THF (20 ml) was added a solution of LiOH (0.5 M, 2 equiv.) and the mixture was stirred for 30 min at room temperature. The reaction mixture was washed twice with Et 2 O. The aqueous layer was acidified to pH 1 with HCl and extracted twice with Et 2 O. The last two organic layers were dried over MgSO 4 and concentrated under reduced pressure to give the N-(4-pentenoyl)-L-alanine as a yellowish oil (48% yield) which was used without further purification. To a solution of this compound (325 mg, 1.9 mmol) in CH 3 CN (5 ml) were added trietylamine (1.14 ml, 8.17 mmol) and chloroacetonitrile (300 ml, 4.75 mmol); the mixture was stirred overnight at room temperature and concentrated to dryness under reduced pressure. The residue was dissolved in AcOEt and H 2 O, the organic layer was dried over MgSO 4 
Semi-synthesis of Ala-tRNA Ala analogues
Chemical aminoacylation of the hybrid dinucleotide 5 0 -phospho-2 0 -deoxyribocytidylylriboadenosine (pdCpA) by N-(4-pentenoyl)-L-alanine cyanomethyl ester was performed as previously described (24, 25 (27) . The structure was energy minimized in 100 steps with a dielectric constant of 1, using the CNS program (28). The puromycin: leucyl/phenylalanyl-tRNA synthetase complex was used to position the 3 0 -end of the acceptor arm of tRNA Ala since this transferase and FemX Wv share a common fold indicating that their tRNA-binding sites are likely to be structurally related (11, 27) .
RESULTS
In vivo specificity of the FemX Wv transferase
Cytoplasmic peptidoglycan precursors were extracted from W. viridescens to identify the amino acid incorporated by FemX Wv in vivo (Figure 1 (Figure 2 and data not shown). The second and third residues were added after the transfer of the phospho-MurNAc-peptide moiety of the precursor to the lipid carrier since a single L-Ala residue was detected in the nucleotide precursors (Figure 1 ). The peptidoglycan of W. viridescens contained multimeric structure ranging from dimers to hexamers. The cross-bridges contained the sequence L-Ala-L-Ser and L-Ala-L-Ser-L-Ala indicating that the D,D-transpeptidases used acceptor containing at least two residues in their side chains.
In conclusion, analyses of the structure of peptidoglycan and its precursors indicated that FemX Wv only adds L-Ala at the first position of L-Ala-L-Ser and L-Ala-LSer-L-Ala side chains. Incorporation of L-Ala substitutes in more than 1% of the precursors would have been easily detected since peptidoglycan fragments containing Gly, D-Asp and L-Ser are readily detected by electrospray mass spectrometry (16, 17) .
Specificity of the FemX Wv transferase for tRNAs obtained by in vitro transcription
In order to compare the catalytic efficiency of FemX Wv with different aminoacyl-tRNAs, kinetics of synthesis of UDP-MurNAc-hexapeptides containing Ala ( Figure 3A) , Ser ( Figure 3B ), and Gly ( Figure 3C ) were performed at different aminoacyl-tRNA concentrations. The turnover number of FemX Wv was deduced from the individual kinetics and plotted against the aminoacyl-tRNA Figure 2 . Coupled assay for UDP-MurNAc-hexapeptide synthesis. The auxiliary system used to generate aminoacyl-tRNA (AA-tRNA) involves acylation of tRNA with a radiolabeled amino acid by aminoacyl-tRNA synthetases (AA-RS). Purified alanyl-tRNA synthetase (AlaRS), seryl-tRNA synthetase (SerRS) and glycyl-tRNA synthetase (GlyRS) were used in this study. FemX Wv transfers the amino acids from the aminoacyl-tRNAs to the e -amino group of L-Lys at the third position of UDP-MurNAc-pentapeptide to form the corresponding hexapeptide which was determined by liquid scintillation.
AA-RS
concentrations ( Figure 3D-F) . The linear relationship indicates that the reaction conditions meet the first order conditions with respect to aminoacyl-tRNAs in agreement with the K m value of 1.7 mM previously reported for AlatRNA Ala (13 Table 1 ).
In vitro specificity of the FemX Wv transferase for natural tRNAs
The relative efficiency of FemX Wv with natural tRNAs from W. viridescens, S. aureus, E. faecalis and E. faecium was evaluated based on determination of the turnover number of the enzyme at four aminoacyl-tRNA concentrations as performed for in vitro transcripts (data not shown and Table 1 ). The highest FemX Wv turnover Figure 4 ) were tested as substrates of AlaRS and FemX Wv in the coupled assay (Figure 2 ) for UDP-MurNAc-hexapeptide synthesis. Deletion of the anticodon and pseudouridine arms of tRNA Ala resulted in two minihelices, with or without bulged U 8 , which were both functional in the coupled assay. Formation of UDP-MurNAc-hexapeptide was also obtained with a 24-nt microhelix consisting of the acceptor stem of tRNA Ala and a loop of 6 nt. Finally, an RNA duplex consisting only of the acceptor stem was also functional. These results indicate that the bases essential for FemX Wv and AlaRS activities are all located within the acceptor stem of tRNA Ala . We therefore focused the following mutagenesis studies on the acceptor stem of tRNA Ala although we have not excluded the possibility that additional region of the tRNA might modulate enzyme activity.
Development and validation of a novel method for saturation mutagenesis of the acceptor stem of tRNA
Ala
To facilitate site-directed mutagenesis of the DNA template for in vitro transcription of tRNA Ala by T7 RNA polymerase, we have developed a method based on PCR amplification using mutagenic primers. In the classical method (21), the 5 0 -end of the DNA template that determines the 3 0 -end of the run off transcript is generated by digestion of a plasmid by the restriction endonuclease BstNI. In this study, the 5 0 -end of a primer used for PCR amplification of the DNA template provided an alternate way to define the 3 0 -end of the tRNA transcript. Twenty-four mutagenic primers were used to introduce all possible single nucleotide substitutions in positions C 69 to A 76 of the acceptor stem. The 5 0 -end of the in vitro transcript was defined by the localization of the T7 promoter, which was incorporated at the 5 0 -end of the second primer used for PCR amplification. The mutagenic primers also contained the sequence corresponding to bases 1 to 22 of tRNA Ala , thereby allowing the introduction of all possible single nucleotide substitutions in positions 1 to 4. The plasmid template used for PCR amplification did not contain the T7 promoter sequence. Thus, the wild-type tRNA Ala sequence could not originate from transcription of the plasmid template. In preliminary experiments, we compared tRNA Ala with the wild-type sequence obtained by in vitro transcription of DNA matrices generated by PCR or by the classical digestion of a plasmid template with BstNI. The two types of tRNA Ala preparations were equivalent in conditions where the tRNA substrate and FemX Wv were rate limiting (data not shown). We also checked that the fidelity of the DNA polymerase used for the PCR was sufficient to avoid false positives. This was established by showing that several substitutions abolished formation of the UDP-MurNAc-hexapeptide product of FemX Wv in the coupled assay ( Figure 5 , see subsequently).
Impact of single nucleotide substitutions in tRNA Ala
Nucleotide substitutions were introduced at positions 1 to 4 of tRNA Ala and residual activity was determined by the coupled AlaRS-FemX Wv assay ( Figure 5 ). All substitutions at position 3 abolished formation of the UDPMurNAc-hexapeptide indicating that G 3 is essential. At position 2, low residual activity was detected only for the G 2 A and G 2 C substitutions. All substitutions were tolerated at positions 1 and 4 with various impacts on residual activities. Analysis of the complementary strand by the same method identified three essential bases (C 72 , C 71 and U 70 ). Relatively high residual activities were detected for position C 69 . Several substitutions were tolerated in the single-strand ACCA extremity of the acceptor stem and none of the four bases was essential.
In conclusion, analysis of single substitutions identified four bases, C 72 , C 71 and G 3 -U 70 that were essential for synthesis of UDP-MurNAc-hexapeptide by AlaRS and FemX Wv .
Impact of double nucleotide substitutions in tRNA Ala
All 15 possible combinations of nucleotides were introduced in base pairs G 1 -C 72 , G 2 -C 71 , G 3 -U 70 and G 4 -C 69 using pairs of mutagenic primers and residual activity was determined in the coupled AlaRS-FemX Wv ( Figure 6 ). . Thus, modification of the sequence rather than destabilization of the acceptor stem was the primary impact of nucleotide substitutions at these two positions. Semi-synthesis of analogues of Ala-tRNA Ala Detection of UDP-MurNAc-hexapeptide synthesis in the coupled assay used above implies that nucleotide substitutions are tolerated both by the AlaRS and by FemX Wv . Thus, the assay provides a rapid method to determine whether nucleotide substitutions are tolerated by FemX Wv provided that the modified tRNA Ala molecules are substrate of the AlaRS. The assay is highly sensitive to qualitatively detect residual activity since each tRNA molecule can participate to several catalytic cycles (Figure 2) . However, the absence of UDP-MurNAchexapeptide synthesis in the coupled assay, as observed for the substitutions at positions C 72 , C 71 and G 3 -U 70 , may indicate that the modified tRNAs are not substrate of AlaRS although they can be used by FemX Wv . Semisynthesis of Ala-tRNA Ala analogues harboring these substitutions was therefore developed to obtain esterified tRNA Ala independently from the AlaRS ( Figure 7A ). This approach was originally developed to introduce nonnatural amino acids into proteins by using in vitro coupled transcription-translation systems (30) . Briefly, a dinucleotide esterified by an amino acid analogue is obtained by organic synthesis ( Figure 7B ) and added to an incomplete tRNA lacking the 3 0 -end CA dinucleotide using the T4 RNA ligase (30) . The ligation restores the complete tRNA sequence with a 3 0 esterified residue. A 2 0 deoxycytidine is incorporated into the dinucleotide to facilitate its synthesis. In preliminary experiments, we generated a FemX Wv substrate by this approach which contained the wild-type tRNA Ala sequence and L-Ala as the 3 0 amino acyl group ( Figure 7C were substrate of FemX Wv . In contrast, C 72 and C 71 , identified as essential in the coupled assay ( Figure 5 , above), were also found to be essential for FemX Wv activity since introduction of the C 72 G and C 71 G substitutions by semi-synthesis abolished formation of UDP-MurNAc-hexapeptide. In conclusion, C 72 and C 71 , but not G 3 -U 70 , were essential for FemX Wv indicating that the mode recognition of the tRNA body by this enzyme and AlaRS are different.
DISCUSSION
Synthesis of the side chain of peptidoglycan precursors by Fem transferases in Gram-positive bacteria implies that translation and peptidoglycan synthesis share common aminoacyl-tRNA synthetases and tRNAs. Fem transferases have evolved to redirect a portion of the aminoacyl-tRNAs toward peptidoglycan synthesis. The specificity of these enzymes is essential since the side chain is used by the transpeptidases in the last cross-linking step of peptidoglycan synthesis (Introduction section and Figure 1A) . In this study, we have investigated tRNA recognition by a model transferase, FemX Wv from W. viridescens, to identify and compare the identity determinants used by aminoacyl-tRNA synthetases and Fem transferases.
In vivo evaluation of the specificity of FemX Wv based on extensive analyses of the structure of mature peptidoglycan and its precursors (Figure 1 ) revealed that this enzyme exclusively uses Ala-tRNA Ala for aminoacyl transfer. Evaluation of homologous tRNAs extracted from W. viridescens indicated that FemX Wv is also highly specific in vitro since Ser-tRNA Ser and Gly-tRNA Gly were used 100-and 4000-fold less efficiently than Ala-tRNA Ala , respectively ( Table 1) . Comparison of in vitro transcripts and natural tRNAs revealed similar catalytic efficiencies indicating that post-transcriptional modifications do not contribute to discrimination between Ala-tRNA Ala and Ser-tRNA Ser (Table 1 ). In contrast, unknown posttranscriptional modifications might act as negative (anti-determinant) elements for Gly-tRNA Gly since incorporation of Gly was 25-fold less efficient with natural tRNAs than with in vitro transcripts ( Table 1) . FemX Wv retained preferential incorporation of alanine with heterologous tRNAs extracted from related Gram-positive species, although the capacity of the enzyme to discriminate between the different tRNAs was reduced mainly because heterologous Ala-tRNA Ala were used less efficiently than Ala-tRNA Ala from W. viridescens. The use of heterologous Ala-tRNA Ala and Ser-tRNA Ser from E. coli in a previous study may therefore account for the reported poor discrimination of the two aminoacyl-tRNAs by FemX Wv (14) .
To identify the tRNA elements essential for FemX Wv activity, deletions were introduced into tRNA Ala revealing that the acceptor stem is sufficient for the alanine transferase activity of FemX Wv (Figure 4 ). Site-directed mutagenesis identified four bases (C 72 , C 71 and G 3 -U 70 ) essential for UDP-MurNAc-hexapeptide synthesis in the coupled AlaRS-FemX Wv assay ( Figure 5 ). Introduction of double nucleotide substitutions showed that C 72 and C 71 were both essential since destabilization of the acceptor stem was not the primary impact of nucleotide substitutions at these two positions ( Figure 6 ). Site-directed mutagenesis ( Figures 5 and 6 ) combined to semi-synthesis ( Figure 7) showed that the identity determinants of the E. faecalis AlaRS and FemX Wv are overlapping but distinct ( Figure 8A ). In particular, the G 3 -U 70 base pair of tRNA Ala , which is the main identity determinant of AlaRS from bacteria, archaea and eukarya (31, 32) , occasionally found at positions 2-71 (33,34), was nonessential to the alanyl transferase activity of FemX Wv since nucleotide substitutions at positions 3 and 70 were both tolerated by the enzyme ( Figure 8A The capacity of FemX Wv to discriminate between different aminoacyl-tRNA is likely to depend both upon the tRNA body and the esterified amino acid as demonstrated for elongation factor EF-Tu that delivers aminoacyl-tRNAs to the ribosome during translation (36) . For this protein, the affinities for the tRNA and the amino acid have compensatory role to ensure roughly equivalent affinities for all elongator aminoacyl-tRNAs. The sequence-dependent recognition of the tRNA body involves hydrogen bonding between a Glu residue of the protein and the amino group of a guanine located in the minor groove of the T-stem (base pair 51-63). AminoacyltRNA recognition by the eubacterial leucyl/phenylalanyltRNA-protein transferase (L/F-transferase) involves a different mechanism (27) . This enzyme conjugates leucine or phenylalanine to the N-terminus of proteins triggered to proteolytic degradation using Leu-tRNA Leu or PhetRNA Phe as a substrate. The C-terminal domain of L/F-transferase belongs to the GCN5-related N-transferase fold as the two domains of FemX Wv (11) . The enzyme contains a hydrophobic pocket that accommodates Leu and Phe (and Met and Trp less efficiently) ensuring amino acid specificity (27) . Recognition of the tRNA body occurs in a sequence-independent manner. Based on modeling, recognition involves the phosphate backbone of the bottom region of the D-stem and of the 3 0 region of the acceptor stem. The recognition of amino acyl-tRNAs by L/F-transferase and EF-Tu is competitive. It has been proposed that L/F-transferase might overcome this competition by using a different site in the aminoacyltRNAs, presumably in the D-loop, that does not overlap with the EF-Tu binding site. A similar mechanism may operate for FemX Wv which is expected to compete with EF-Tu for uptake of aminoacyl-tRNAs.
In conclusion, modeling and mutagenesis of tRNA Ala has provided key information for rational design of FemX Wv inhibitors since the bases essential for FemX Wv activity were mapped in a relatively small portion of the . Design of substrate analogues should therefore target this region of the aminoacyl-tRNA substrate. In addition, the different modes of recognition of the acceptor stem by FemX Wv and the AlaRS suggests that it will be feasible to achieve inhibitor selectivity for the peptidoglycan biosynthetic enzyme.
